These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 28647886)
1. Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors. Pridgeon MG; Grohar PJ; Steensma MR; Williams BO Curr Osteoporos Rep; 2017 Aug; 15(4):239-246. PubMed ID: 28647886 [TBL] [Abstract][Full Text] [Related]
2. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies? Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265 [TBL] [Abstract][Full Text] [Related]
3. Wnt pathway in osteosarcoma, from oncogenic to therapeutic. Cai Y; Cai T; Chen Y J Cell Biochem; 2014 Apr; 115(4):625-31. PubMed ID: 24190862 [TBL] [Abstract][Full Text] [Related]
4. Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States. Pedersen EA; Menon R; Bailey KM; Thomas DG; Van Noord RA; Tran J; Wang H; Qu PP; Hoering A; Fearon ER; Chugh R; Lawlor ER Cancer Res; 2016 Sep; 76(17):5040-53. PubMed ID: 27364557 [TBL] [Abstract][Full Text] [Related]
5. Wnt Signaling in Osteosarcoma. Singla A; Wang J; Yang R; Geller DS; Loeb DM; Hoang BH Adv Exp Med Biol; 2020; 1258():125-139. PubMed ID: 32767238 [TBL] [Abstract][Full Text] [Related]
6. The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling. Hawkins AG; Basrur V; da Veiga Leprevost F; Pedersen E; Sperring C; Nesvizhskii AI; Lawlor ER Mol Cell Proteomics; 2018 May; 17(5):901-912. PubMed ID: 29386236 [TBL] [Abstract][Full Text] [Related]
7. Targeting WNT5B and WNT10B in osteosarcoma. Miranda-Carboni GA; Krum SA Oncotarget; 2024 Aug; 15():535-540. PubMed ID: 39102216 [TBL] [Abstract][Full Text] [Related]
8. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma. Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891 [TBL] [Abstract][Full Text] [Related]
9. Wnt signaling in osteosarcoma. Lin CH; Ji T; Chen CF; Hoang BH Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167 [TBL] [Abstract][Full Text] [Related]
10. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma. Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675 [TBL] [Abstract][Full Text] [Related]
11. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway. Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914 [TBL] [Abstract][Full Text] [Related]
13. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types. Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA KCNQ1OT1 contributes to tumor growth and activates Wnt/β‑catenin signaling in osteosarcoma by targeting the miR‑3666/KLF7 axis. Huang A; Jin S; Han W; Wang Y; Ma S; Wang Z; Lin K; Zou Q; Zhou J; Li Z; Chen L Int J Mol Med; 2021 Jan; 47(1):387-396. PubMed ID: 33416089 [TBL] [Abstract][Full Text] [Related]
15. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway. Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249 [TBL] [Abstract][Full Text] [Related]
16. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis. Zhu B; Cheng D; Li S; Zhou S; Yang Q Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247 [TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model. Goldstein SD; Trucco M; Bautista Guzman W; Hayashi M; Loeb DM Oncotarget; 2016 Apr; 7(16):21114-23. PubMed ID: 27049730 [TBL] [Abstract][Full Text] [Related]
18. Convallatoxin suppresses osteosarcoma cell proliferation, migration, invasion, and enhances osteogenic differentiation by downregulating parathyroid hormone receptor 1 (PTHR1) expression and inactivating Wnt/β-catenin pathway. Liu X; Geng Z; Ding X; Lou Y; Zhang X Bioengineered; 2022 May; 13(5):13280-13292. PubMed ID: 35635031 [TBL] [Abstract][Full Text] [Related]
19. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors. Machado I; Navarro S; Giner F; Alberghini M; Bertoni F; Llombart-Bosch A Virchows Arch; 2010 Jul; 457(1):87-9. PubMed ID: 20552365 [No Abstract] [Full Text] [Related]
20. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway. Jiang Z; Jiang C; Fang J Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]